Company profile
NanoLogix, Inc.
OTC: NNLX · Healthcare · Biotechnology
#1103 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 35
v0.1 · 5/100 weight · pillars only
↑ 3-yr revenue growth, balance-sheet leverage · ↓ growth stability, market scale
Methodology →Revenue TTM
$35.6k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.3M
Employees
7
as of 2026-08-03
Market cap
$9.6k
as of 2026-08-03
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$35.6k$35.6k2013
Net income-$1.3M-$1.3M2013
Operating income-$1.3M-$1.3M2013
Total assets$726.6k$726.6k2013
Liabilities$116.0k$116.0k2013
Equity$610.7k$610.7k2013
Revenue trend
FY2006 – FY2013 · USD
FY06
FY07
FY08
FY09
FY10
FY11
FY12
FY13
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is NanoLogix, Inc.’s revenue?
NanoLogix, Inc. booked $35.6k in FY2013 revenue, contracting 60% year over year — slower than 84% of Healthcare companies we track, at a -3631.2% net margin.
Peers · Healthcare
GridAI Technologies Corp.30DForte Biosciences, Inc.26DLyell Immunopharma, Inc.31DMountain Valley MD Holdings Inc.——Cognetivity Neurosciences Ltd.——CuraScientific Corp——Neighbors
Trumbull →Key facts
CEOBret T. Barnhizer
SectorHealthcare
IndustryBiotechnology
HeadquartersHubbard, OH
ExchangeOTC: NNLX
Employees7
IPO date2009-09-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.